| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |